New Treatment Using Transarterial Chemoperfusion Shows Promise for...
Malignant pleural mesothelioma is an aggressive tumor primarily caused by exposure to asbestos. While there is currently no cure, researchers continue to discover new methods in treating symptoms. A...
View ArticleKeytruda Approved by FDA for Further Potential Treatments of Mesothelioma
Keytruda, an antibody drug used in cancer immunotherapy manufactured by Merck and also known as Pembrolizumab, has been approved by the FDA for treatment of solid tumor cancers. Previously, the drug...
View ArticleNew Study Shows LMB-100 Can Be Even More Effective Paired with Keytruda for...
A new study published by the Science Translational Medicine journal showed that, for a small cohort, LMB-100 could be even more effective when paired with Keytruda for treating patients with...
View ArticleMesothelioma Patients Can Safely Get Treatment Through Telehealth and Video
The COVID-19 virus has disrupted all of our lives and routines. Things that we always did and places we always went are no longer available. The pandemic has forced us to all look at things we...
View ArticlePairing Machine Learning with PET Scans Can Help Predict Mesothelioma Outcomes
The EJNMMI Research medical journal recently published an article entitled “FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients” that outlines a study wherein 72...
View ArticleClinical Trial of Imfinzi (Durvalumab) in Conjunction with Chemotherapy...
Immuno-Oncology News recently published results of a Phase 2 clinical trial of the immuno-checkpoint inhibitor Imfinzi (durvalumab) for patients diagnosed with malignant pleural mesothelioma. The...
View ArticleNew Dual-Immunotherapy Regimen Proves Effective for Mesothelioma Patients in...
Dr. Paul Baas of the Netherlands Cancer Institute and the University of Leiden in Amsterdam recently presented on the CheckMate 743 study at the International Association for the Study of Lung Cancer...
View ArticleFirst New Drug Treatment for Mesothelioma Approved by FDA in Over 16 Years
For the first time in 16 years, the U.S. Food & Drug Administration has approved a new drug combination specifically for the treatment of malignant pleural mesothelioma. The two drugs, which are to...
View ArticleMesothelioma Patient on Importance of Staying Positive During Treatment
Once a person is diagnosed with malignant mesothelioma and decides on a treatment plan, the anticipation for treatment to begin – and the reality of when it does begin – can be a challenging time....
View ArticleCommitment is a Key Ingredient for Mesothelioma Treatment
Having been involved with the mesothelioma community for many years, one of the defining qualities of this community is the commitment of the team. The team the patients and their families meet and the...
View Article
